How Placebos Beat Drugs in Drug Trials

Henry Beecher, an anesthesiologist who had treated wounded soldiers in World War II, ran out of morphine on the field. He sometimes injected saline instead, told the men it was painkiller, and watched roughly 40 percent of them get measurable relief. In 1955 he published "The Powerful Placebo" in JAMA, arguing that any honest drug trial had to compare against a fake one because the fake one was doing real work.

That paper is why every modern drug trial has a control arm. It's also why the FDA can demand evidence that a new drug beats sugar by a meaningful margin — a bar a surprising number of approved medications, especially antidepressants, only barely clear.

The weirder findings came later. Color matters: red and orange placebos work better as stimulants, blue and green as sedatives. Size matters in opposite directions depending on context — a tiny pill reads as potent in some studies, a large one in others. Brand-name labels on identical sugar pills outperform generic labels. Saline injections beat oral placebos. Sham surgery — where the surgeon makes an incision and sews it back up without doing anything inside — has, in several trials, matched real arthroscopic knee surgery for osteoarthritis pain.

None of this means the underlying disease is imagined. A 2010 trial at Harvard's Beth Israel Deaconess gave irritable bowel syndrome patients pills clearly labeled "placebo" and explained they contained no active ingredient. The patients still improved more than the no-treatment group. Expectation, ritual, and the act of being cared for produce real neurochemistry. The brain's opioid system fires whether the pill is morphine or chalk.

What the placebo proves is not that medicine is fake. It's that part of medicine has always been theater, and the theater works.